Literature DB >> 10559351

Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

V Varthakavi1, P J Browning, P Spearman.   

Abstract

Human immunodeficiency virus (HIV) and Kaposi's sarcoma-associated herpesvirus (KSHV) coinfect many individuals in North America and in parts of Africa. Infection with HIV is a leading risk factor for the development of Kaposi's sarcoma (KS). In this study, we tested the hypothesis that HIV infection of common or adjacent cells would stimulate replication and spread of KSHV. Infection of a primary effusion lymphoma cell line by vesicular stomatitis virus type G-pseudotyped HIV type 1 led to a rapid induction of lytic-phase KSHV replication. Induction of lytic KSHV replication by HIV required active replication of HIV. The addition of the nucleoside reverse transcriptase inhibitor azidothymidine or the protease inhibitor indinavir to the culture prevented HIV spread and inhibited the associated induction of KSHV lytic replication. Lytic replication occurred in both HIV-infected and HIV-uninfected cells within the culture, and could be induced in uninfected cells via a soluble factor released from the HIV-infected cells. Transmission of infectious KSHV to an uninfected target cell was enhanced by HIV replication and was inhibited by antiretroviral drugs. These results may have implications for the pathogenesis and treatment of KS in individuals coinfected with KSHV and HIV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559351      PMCID: PMC113088     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  B Ensoli; G Barillari; R C Gallo
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

Review 2.  Generation of high-titer pseudotyped retroviral vectors with very broad host range.

Authors:  J K Yee; T Friedmann; J C Burns
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

3.  Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.

Authors:  B Ensoli; R Gendelman; P Markham; V Fiorelli; S Colombini; M Raffeld; A Cafaro; H K Chang; J N Brady; R C Gallo
Journal:  Nature       Date:  1994-10-20       Impact factor: 49.962

4.  Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.

Authors:  T Gardella; P Medveczky; T Sairenji; C Mulder
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

5.  Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.

Authors:  L Blum; C Pellet; F Agbalika; G Blanchard; P Morel; F Calvo; C Lebbé
Journal:  AIDS       Date:  1997-11       Impact factor: 4.177

Review 6.  Pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  B Ensoli; G Barillari; R C Gallo
Journal:  Hematol Oncol Clin North Am       Date:  1991-04       Impact factor: 3.722

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.

Authors:  Y Q Huang; J J Li; M H Kaplan; B Poiesz; E Katabira; W C Zhang; D Feiner; A E Friedman-Kien
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

9.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

Authors:  B Ensoli; S Nakamura; S Z Salahuddin; P Biberfeld; L Larsson; B Beaver; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

10.  Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls.

Authors:  P J Browning; J M Sechler; M Kaplan; R H Washington; R Gendelman; R Yarchoan; B Ensoli; R C Gallo
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

View more
  33 in total

Review 1.  Viruses and human cancer: from detection to causality.

Authors:  Ronit Sarid; Shou-Jiang Gao
Journal:  Cancer Lett       Date:  2010-10-23       Impact factor: 8.679

2.  Toll-like receptor signaling controls reactivation of KSHV from latency.

Authors:  Sean M Gregory; John A West; Patrick J Dillon; Chelsey Hilscher; Dirk P Dittmer; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

3.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.

Authors:  Devon A Gregory; Terri D Lyddon; Marc C Johnson
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

5.  Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  T L Morris; R R Arnold; J Webster-Cyriaque
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.

Authors:  Fang Lu; Jing Zhou; Andreas Wiedmer; Kevin Madden; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.

Authors:  Fan Xiu Zhu; Narayanan Sathish; Yan Yuan
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

8.  Characterization of a myristoylated, monomeric HIV Gag protein.

Authors:  Jun Dou; Jaang-Jiun Wang; Xuemin Chen; Hua Li; Lingmei Ding; Paul Spearman
Journal:  Virology       Date:  2009-03-12       Impact factor: 3.616

9.  HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.

Authors:  Qin Yan; Chenyou Shen; Jie Qin; Wan Li; Minmin Hu; Hongmei Lu; Di Qin; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 10.  Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.

Authors:  Kevin Brulois; Jae U Jung
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.